• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Are drug-eluting stents a waste of money? | MassDevice.com On Call

Are drug-eluting stents a waste of money? | MassDevice.com On Call

August 16, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Choosing bare metal stents over their drug-eluting cousins may decrease per-patient treatments costs by $401 without significantly increasing adverse health outcomes, according to a study published in the journal Circulation.

According to a registry of cardiovascular treatment, DES use decreased from 92 percent to 68 percent from 2004 to 2007, largely on concerns about possible risks. Despite the dramatic drop in use, incidence of target lesion revascularization increased only 1 percent (from 4.1 percent to 5.1 percent), and rates of death and MI didn’t change.

"The bottom-line was that using drug-eluting stents in a relatively unselected way was only resulting in marginal improvement compared to more selective use," senior author David Cohen said in a press release.

UK firm unveils world’s first biodegradable esophageal stent

An esophageal stent developed by Yorkshire-based UKMed!cal promises to be the first such device to fully biodegrade in 11 to 12 weeks, Medilink reported.

FDA wants deeper access to electronic health data

The FDA is considering using electronic medical records to help keep tabs on drugs after they’ve been cleared for market, Fierce EMR reported.

Wearable ear device helps treat scar tissue

A pressure device worn overnight to supplement other therapy stopped keloid growth in patients with scar tissue in the ears, according to a press release.

Dems demand changes in Medicare nursing homes

Congressional Democrats demanded changes in the way Medicare reimburses nursing homes, pointing to a Government Accountability Office report finding that private investment home "had a higher overall rate of deficiencies," Healthwatch reported.

Filed Under: Food & Drug Administration (FDA), Medicare, News Well Tagged With: Bioabsorbable Stents, UKMed!cal

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy